Patents, Patents
Sorafenib: a divergent case, like so many others
By Judgment of 30 September 2024, the Commercial Court No. 1 of Barcelona dismissed the infringement action brought by three companies of the BAYER Group against four companies that had launched generic drugs based on the active ingredient sorafenib in the form of its tosylate salt on the Spanish market. The Court, upholding the defendants’ …
Patents
The decision of the spanish Supreme Court in relation to preventive writs and the competent jurisdiction (Apixaban)
It has been some months since the Supreme Court’s Order of 24 April 2024, which decided in relation to two questions of jurisdictional competence. This link provides access to the decision. The facts of the case that led to the Supreme Court’s decision were as follows: The ‘preventive writ’ is the formula adopted by the …
INSIGHTS
Unfair Competition
The use of protective writs in unfair competition cases in Spain
Patents, Unfair Competition
The intersection between competition law and patent law: the fingolimod case
General, Industrial Property, VQR
